The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Brukinsa (zanubritinib)
Australian Public Assessment Report
Device/Product Name
Brukinsa
Active ingredients
Zanubrutinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01012-1-4
Submission Type
Extension of indications
Decision
Approved